Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind placebo-controlled phase IV trial of live attenuated herpes zoster vaccine in adults aged 40 and above
CTR20251313Phase 4Active
- Sponsor
- Changchun Baimu Biotechnology
- Start
- May 2025
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of zoster vaccine live in herpes zoster (HZ), sponsored by Changchun Baimu Biotechnology. Started May 2025; status: active.
02
Drugs
zoster vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20251313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251313.